Bexsero, meningitis B vaccine vaccination campaign results released
Novartis has announced the initial results of a large-scale vaccination campaign with Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) to help protect against meningitis B within the Saguenay-Lac-Saint-Jean More...
Bexsero, meningitis B vaccine, receives FDA Breakthrough Therapy designation
PRESS RELEASE Novartis announced today that Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) has received a Breakthrough Therapy designation from the United States Food and Drug Administration More...
British health officials recommend Bexsero as part of routine childhood immunization schedule
The Joint Committee on Vaccination and Immunisation (JCVI) in Great Britain has recommended the inclusion of the meningitis B vaccine, Bexsero, to be part of the routine childhood immunization schedule, according More...
Princeton meningitis strain confirmed in Drexel fatal case
Eight days ago, the community at Drexel University in Philadelphia was shocked by the sudden death of 19-year-old sophomore Stephanie Ross. At the time it was suspected that the cause of her dearth was bacterial More...
‘Probable’ meningococcal meningitis case reported at Princeton, could be sixth case this year
Princeton University officials have announced that a female student with “probable meningococcal disease” may be the sixth bacterial meningitis case since the spring, according to a Princeton press release More...
